Business Context and Reporting Period
Company: Community Health Systems, Inc. (CHS)
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2024
Overview: CHS is a leading provider of healthcare services operating 76 affiliated hospitals with over 11,000 beds across 39 markets in 15 states. The company operates a single reportable segment: hospital operations, which includes acute care hospitals and related outpatient facilities.
Key Financial Metrics
| Metric (in millions) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net Operating Revenues | $12,634 | $12,490 | $12,211 |
| Net (Loss) Income Attributable to CHS | $(516) | $(133) | $46 |
| Adjusted EBITDA | $1,540 | $1,453 | $1,466 |
| Adjusted EBITDA Margin | 12.2% | 11.6% | 12.0% |
| Operating Cash Flow | $480 | $210 | $300 |
| Total Debt (Long-term + Current) | $11,452 | $11,487 | N/A |
| ABL Facility Borrowing Capacity | $491 (Available) | N/A | N/A |
Note: Adjusted EBITDA is a non-GAAP measure. Net loss for 2024 includes significant non-cash charges and one-time items.
Material Changes vs. Prior Period
- Revenue Growth: Net operating revenues increased 1.2% to $12.6 billion. On a same-store basis, revenues increased 5.5%, driven by higher inpatient/outpatient volumes and reimbursement rates, partially offset by lower acuity.
- Profitability Decline: Net loss attributable to stockholders widened significantly from $(133) million in 2023 to $(516) million in 2024. This deterioration was primarily driven by:
- A $301 million net expense for impairment and loss on sale of businesses (compared to an $87 million gain in 2023).
- A $149 million increase in the professional liability claims accrual due to adverse claim developments and social inflation.
- $52 million in business transformation costs related to ERP implementation.
- Volume Trends: Consolidated inpatient admissions decreased 3.2% and adjusted admissions decreased 3.4% year-over-year. However, same-store admissions increased 3.2% and 2.7% respectively, indicating organic growth in retained facilities.
- Divestitures: The company completed the sale of two hospitals in 2024 (Tennova Healthcare - Cleveland and Davis Regional Medical Center) for net proceeds of approximately $174 million.
Guidance, Outlook, and Risks
- Capital Expenditures: CHS expects total capital expenditures of approximately $350 million to $400 million in 2025.
- Debt Management: The company refinanced its ABL Facility in June 2024, extending maturity to June 2029. Approximately $20 million of debt is due within the next 12 months, with significant maturities in 2027 ($2.466 billion). The company maintains approximately $491 million in available borrowing capacity under its ABL facility.
- Regulatory Risks: Significant uncertainty exists regarding Medicare and Medicaid reimbursement rates, particularly concerning the expiration of enhanced ACA subsidies in 2025 and potential changes to Medicaid expansion funding. Recent Supreme Court decisions (e.g., Loper Bright) increase judicial scrutiny of federal agency actions, potentially impacting healthcare regulations.
- Operational Risks: The company faces ongoing challenges with labor costs, physician recruitment, and professional liability claims. A Punta Gorda, Florida hospital has indefinitely suspended inpatient operations due to hurricane damage, though a sale agreement is in place.
- Legal Proceedings: CHS is subject to various legal proceedings, including a DOJ investigation regarding a former employee's allegations and a criminal investigation into a former medical director's conduct. Management does not believe these will have a material adverse effect on liquidity but notes potential impacts on results of operations.
Investor Verification Checklist
- Professional Liability Reserves: Verify the sustainability of the $149 million increase in the professional liability accrual and the adequacy of insurance coverage limits given "social inflation" trends.
- Divestiture Pipeline: Monitor the completion status and final proceeds of pending hospital sales (ShorePoint Health Port Charlotte/Punta Gorda, Lake Norman Regional Medical Center, and Merit Health Madison/Biloxi interests).
- Debt Covenants: Review compliance with the ABL Facility's consolidated fixed charge coverage ratio, which is triggered if availability falls below $95 million or 10% of the borrowing base.
- Reimbursement Rates: Assess the impact of potential Medicaid funding changes in non-expansion states (e.g., Texas, Florida, Alabama) where CHS has significant revenue concentration.
- ERP Implementation: Evaluate the realization of cost savings from the new enterprise resource planning (ERP) system and associated business transformation costs.